EA200400428A1 - Применение лютеинизирующего гормона при контролируемой гиперстимуляции яичников - Google Patents

Применение лютеинизирующего гормона при контролируемой гиперстимуляции яичников

Info

Publication number
EA200400428A1
EA200400428A1 EA200400428A EA200400428A EA200400428A1 EA 200400428 A1 EA200400428 A1 EA 200400428A1 EA 200400428 A EA200400428 A EA 200400428A EA 200400428 A EA200400428 A EA 200400428A EA 200400428 A1 EA200400428 A1 EA 200400428A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lute
hormone
efficient
application
ovarian hyperstimulation
Prior art date
Application number
EA200400428A
Other languages
English (en)
Other versions
EA009210B1 (ru
Inventor
Стефен Дж. Хиллир
Колин Майкл Хаулес
Original Assignee
Апплайд Резеч Системз Арс Холдинг Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200400428(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Апплайд Резеч Системз Арс Холдинг Н.В. filed Critical Апплайд Резеч Системз Арс Холдинг Н.В.
Publication of EA200400428A1 publication Critical patent/EA200400428A1/ru
Publication of EA009210B1 publication Critical patent/EA009210B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение связано с новым применением ЛГ и аналогов, обладающих активностью ЛГ, для содействия фолликулогенезу при контролируемой гиперстимуляции яичников (КГЯ), при которой ЛГ или его аналог вводят в течение периода примирования, длящегося с 1 дня приблизительно до 4 дня фазы стимуляции при КГЯ.Отчет о международном поиске был опубликован 2003.04.17.
EA200400428A 2001-09-12 2002-09-12 Способ индукции множественного фолликулогенеза EA009210B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12
PCT/GB2002/004147 WO2003022301A2 (en) 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation

Publications (2)

Publication Number Publication Date
EA200400428A1 true EA200400428A1 (ru) 2004-08-26
EA009210B1 EA009210B1 (ru) 2007-12-28

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400428A EA009210B1 (ru) 2001-09-12 2002-09-12 Способ индукции множественного фолликулогенеза

Country Status (28)

Country Link
US (1) US7341989B2 (ru)
EP (1) EP1434600B1 (ru)
JP (1) JP2005504072A (ru)
KR (1) KR20040032953A (ru)
CN (1) CN1302806C (ru)
AR (1) AR036591A1 (ru)
AT (1) ATE427755T1 (ru)
AU (1) AU2002331939B2 (ru)
BR (1) BR0212502A (ru)
CA (1) CA2457067A1 (ru)
CY (1) CY1110487T1 (ru)
DE (1) DE60231892D1 (ru)
DK (1) DK1434600T3 (ru)
EA (1) EA009210B1 (ru)
ES (1) ES2322136T3 (ru)
HK (1) HK1067866A1 (ru)
HR (1) HRP20040070A2 (ru)
IL (1) IL160781A0 (ru)
ME (1) MEP38808A (ru)
MX (1) MXPA04002125A (ru)
NO (1) NO327154B1 (ru)
PL (1) PL205472B1 (ru)
PT (1) PT1434600E (ru)
RS (1) RS51505B (ru)
SI (1) SI1434600T1 (ru)
UA (1) UA78970C2 (ru)
WO (1) WO2003022301A2 (ru)
ZA (1) ZA200401008B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050058285A (ko) * 2002-06-07 2005-06-16 아레스 트레이딩 에스.에이. 조절된 난소 과자극 방법 및 이런 방법에 이용되는제약학적 키트
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
WO2000067778A1 (en) * 1999-05-07 2000-11-16 Applied Research Systems Ars Holding N.V. Gonadotrophins

Also Published As

Publication number Publication date
PT1434600E (pt) 2009-04-28
ES2322136T3 (es) 2009-06-17
NO20040990L (no) 2004-03-08
WO2003022301A3 (en) 2003-04-17
BR0212502A (pt) 2004-08-24
PL367343A1 (en) 2005-02-21
YU21204A (sh) 2006-08-17
CN1302806C (zh) 2007-03-07
US20050049199A1 (en) 2005-03-03
ATE427755T1 (de) 2009-04-15
UA78970C2 (ru) 2007-05-10
HK1067866A1 (en) 2005-04-22
EP1434600A2 (en) 2004-07-07
DE60231892D1 (de) 2009-05-20
CN1553809A (zh) 2004-12-08
EA009210B1 (ru) 2007-12-28
ZA200401008B (en) 2005-08-31
EP1434600B1 (en) 2009-04-08
CA2457067A1 (en) 2003-03-20
RS51505B (sr) 2011-06-30
NO327154B1 (no) 2009-05-04
PL205472B1 (pl) 2010-04-30
US7341989B2 (en) 2008-03-11
IL160781A0 (en) 2004-08-31
CY1110487T1 (el) 2015-04-29
SI1434600T1 (sl) 2009-06-30
AR036591A1 (es) 2004-09-22
KR20040032953A (ko) 2004-04-17
HRP20040070A2 (en) 2004-10-31
DK1434600T3 (da) 2009-05-25
JP2005504072A (ja) 2005-02-10
MXPA04002125A (es) 2004-07-08
AU2002331939B2 (en) 2007-10-25
WO2003022301A2 (en) 2003-03-20
MEP38808A (en) 2011-02-10

Similar Documents

Publication Publication Date Title
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
DE69940975D1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
DK0736039T3 (da) Forbindelser med væksthormon-frigivende egenskaber
ATE322280T1 (de) Verwendung von daptomycin
DK0566641T3 (da) Anvendelse af human IGF-I.
HUP0302026A2 (hu) Növekedési hormon szekrécióját fokozó triptofánszármazékok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200400428A1 (ru) Применение лютеинизирующего гормона при контролируемой гиперстимуляции яичников
ATE192037T1 (de) Verwendung von arginin als immunstimulator
DE69929188D1 (de) Lysin enthaltende peptide zur behandlung von herzkrankheiten
SE8802569D0 (sv) Improvements in or relation to somatostatins
DK0464105T3 (da) Melaninkoncentrerende hormoner og DNA til ekspression af samme
EA200000378A1 (ru) Усеченные по амино-концу мср-2 как антагонисты хемокинов
ATE447410T1 (de) Verwendung von humanem parathyroid-hormon
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
ATE377026T1 (de) Behandlung von fettleibigkeit
DE69930662D1 (de) Humane rezeptortyrosinkinase
EA200401586A1 (ru) Композиции для терапевтического использования, включающие витамин а, соль металла и инсулин либо гормон роста
ES2135398T3 (es) Compuesto y composiciones de inhibicion de la resorcion osea.
EA200301041A1 (ru) Стимуляция остеогенеза с использованием гибридных белков лиганда для rank
DE69526972D1 (de) Verwendung von Gabapentin in der Behandlung vonAngst - und Panikstörungen
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
EA201000501A1 (ru) Фармацевтическая композиция, содержащая не обладающий нейротоксичностью активатор плазминоген для лечения удара
TH86934B (th) การเสริมที่มีพลาสมิคเป็นสื่อกลางสำหรับการบำบัดรักษาของผู้ป่วยเรื้อรัง

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU